CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers
The dysregulation of PD-1 ligands (PD-L1 and PD-L2) and CTLA-4 ligands (CD80 and CD86) represents a tumor strategy to escape the immune surveillance. Here, the expression of PD-L1, PD-L2, CD80, and CD86 was evaluated at the mRNA level in 94 patients affected by papillary thyroid carcinoma (PTC) and...
Saved in:
Main Authors: | Chiara Tuccilli, Enke Baldini, Salvatore Sorrenti, Antonio Catania, Alessandro Antonelli, Poupak Fallahi, Francesco Tartaglia, Susi Barollo, Caterina Mian, Andrea Palmieri, Giovanni Carbotta, Stefano Arcieri, Daniele Pironi, Massimo Vergine, Massimo Monti, Salvatore Ulisse |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2018/1742951 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
by: Silvia Martina Ferrari, et al.
Published: (2015-01-01) -
The Role of Mannose-Binding Lectin in Severe Sepsis and Septic Shock
by: Gennaro De Pascale, et al.
Published: (2013-01-01) -
Cytokines and HCV-Related Disorders
by: Poupak Fallahi, et al.
Published: (2012-01-01) -
Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic Infection
by: Poupak Fallahi, et al.
Published: (2014-01-01) -
Engineered ipilimumab variants that bind human and mouse CTLA-4
by: Brett Robison, et al.
Published: (2025-12-01)